Current role
Biotechnology · Healthcare
Board Member, CFO
2022-07-08–present
Brian M. Culley
Equibles does not estimate personal net worth.
Get an email with a short summary when Lineage Cell Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LCTX alertsAbout Brian M. Culley
Brian M. Culley is recorded as Board Member at Lineage Cell Therapeutics, Inc. (LCTX) since September 6, 2023 and CFO at Lineage Cell Therapeutics, Inc. (LCTX) since July 8, 2022. The newest filing on record that lists Brian M. Culley as Board Member at Lineage Cell Therapeutics, Inc. (LCTX) is dated April 29, 2026. Lineage Cell Therapeutics, Inc. reported in an 8-K filed September 7, 2023 that Brian M. Culley was appointed director, effective September 6, 2023. Lineage Cell Therapeutics, Inc. reported in an 8-K filed July 7, 2022 that Brian M. Culley was appointed interim Chief Financial Officer, effective July 8, 2022. The proxy statement of Lineage Cell Therapeutics, Inc. reports total compensation of $1,349,913 for Brian M. Culley in fiscal 2020, including a base salary of $551,900. Disclosed compensation is on record for 3 fiscal years. Lineage Cell Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lineage Cell Therapeutics, Inc. includes Jill A. Howe (CFO and Board Member), Alexandra Hernandez (Chief Accounting Officer), Angus C. Russell (Board Member) and 7 others.
“The Company’s shareholders elected the nine nominees named below to the Company’s board of directors to hold office until the Company’s 2024 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”
“Effective July 8, 2022, Brian M. Culley, Lineage's Chief Executive Officer, will serve as Lineage's interim Chief Financial Officer and principal financial officer,”
Affiliation history
-
Current
2023-09-06–present
Last confirmed April 29, 2026
-
Current
2022-07-08–present
Company network
Leadership on record at Lineage Cell Therapeutics, Inc.
- Jill A. Howe CFO, Board Member
- Alexandra Hernandez Chief Accounting Officer
- Angus C. Russell Board Member
- Anula Jayasuriya Board Member
- Anula Jayasuriya, M.D., Ph.D., M.B.A. Board Member
- Brian Culley Board Member
- Deborah Andrews Board Member
- Dipti Amin Board Member
- Don Bailey Board Member
- Dr. Dipti Amin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Lineage Cell Therapeutics, Inc. (LCTX) | Chief Executive Officer and Former Interim Chief Financial Officer | $551,900 | $1,349,913 |
| 2019 | Lineage Cell Therapeutics, Inc. (LCTX) | Chief Executive Officer and Former Interim Chief Financial Officer | $535,800 | $772,742 |
| 2018 | Lineage Cell Therapeutics, Inc. (LCTX) | Chief Executive Officer | $154,923 | $2,862,707 |